Brief: Medigene Raises 2021 FY Forecast
Nov 2 (Reuters) - MEDIGENE AG MDG1k.DE :
* RECEIVES USD2 MLN MILESTONE PAYMENT FROM ROIVANT/CYTOVANT
AND
IMPROVES FINANCIAL FORECAST FOR 2021
* FORECAST FOR TOTAL REVENUES WILL BE INCREASED FROM
PREVIOUSLY
EUR 7-9 MILLION TO A RANGE OF EUR 10-11 MILLION
* EXPECTED EBITDA LOSS IMPROVES TO EUR 7-9 MLN (PREVIOUSLY
EUR
10-17 MLN)
Source text for Eikon: ID:nPexrK7PYa
Further company coverage: MDG1k.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million